LIMS

Some partners are implementing their solutions on the Azure cloud while others will accept output from Microsoft's genomics pipeline as input into their solutions.

Five months after a name change, the former Lab7 Systems has evolved its technology into an app-based platform to support NGS, translational research, and cell therapy.

Agilent said the acquisition will enable it to provide consumers with a single informatics solution across laboratory and operational domains.

Sema4, spun out of Mount Sinai earlier this year, will standardize its two major labs on the Core Informatics Platform for Science as it looks to grow.

The firm will launch two new analysis modules for its Genetic Information Management Suite next year, in addition to a new pharmacogenomics mobile application.

The company is integrating its newly purchased LIMS and genome interpretation and reporting capabilities to provide a single platform for cancer and inherited disease diagnostics.

Core Informatics has satisfied Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice guidelines for the cloud version of its product.

According to Sunquest, UniConnect's technology will augment its own existing solutions for molecular diagnostics.

The combined products will provide customers with a comprehensive solution for managing next-generation sequencing workflows in the lab.

The deal provides Clinical Genomics with a "cornerstone piece" as it readies its blood-based test for colorectal cancer recurrence for commercialization in the US later this year.

Pages

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.